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Abstract
Background: Left ventricular (LV) mechanics are impaired in patients with severe aortic stenosis 
(AS). Transcatheter aortic valve replacement (TAVR) has become a widespread technique for patients 
with severe AS considered inoperable or high risk for traditional open-surgery. This procedure could 
have a positive impact in LV mechanics. The aim of this study was to evaluate the immediate effect of 
TAVR on LV function recovery, as assessed by myocardial deformation parameters.
Methods: One-hundred twelve consecutive patients (81.4 ± 6.4 years, 50% female) from 10 centres 
in Europe with severe AS who successfully underwent TAVR with either a self-expanding CoreValve 
(Medtronic, Minneapolis, MN) or a mechanically expanded Lotus valve (Boston Scientific, Natick, 
MA) were enrolled in a prospective multi-center study. A complete echocardiographic examination was 
performed at baseline and immediately before discharge, including the assessment of LV strain using 
standard two-dimensional images.
Results: Echocardiographic examination with global longitudinal strain (GLS) quantification could 
be obtained in 92 patients, because of echocardiographic and logistic reasons. Between examinations,  
a modest statistically significant improvement in GLS could be seen (GLS% –15.00 ± 4.80 at baseline; 
–16.15 ± 4.97 at discharge, p = 0.028). In a stratified analysis, only women showed a significant im-
provement in GLS and a trend towards greater improvement in GLS according to severity of systolic 
dysfunction as measured by LV ejection fraction could be noted.
Conclusions: Immediate improvement in GLS was appreciated after TAVR procedure. Whether this 
finding continues to be noted in a more prolonged follow-up and its clinical implications need to be as-
sessed in further studies. (Cardiol J 2018; 25, 4: 487–494)
Key words: strain, left ventricular mechanics, echocardiography, aortic stenosis,  
transcatheter aortic valve replacement 
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Introduction
Degenerative aortic stenosis (AS) is one 
of the most common cardiovascular diseases in 
developed countries, surpassed only by hyperten-
sion and coronary artery disease, and the most 
frequent valve disease requiring intervention [1], 
given that valve replacement is the only therapy 
that improves survival [2]. Over the past decade, 
transcatheter aortic valve replacement (TAVR) 
has emerged as a novel therapeutic alternative for 
patients who are considered inoperable or at high 
risk for surgery [3, 4]. 
Aortic stenosis induces a series of adaptive 
responses to pressure overload that translates in 
changes in left ventricular (LV) geometry and per-
formance, although LV volume and ejection fraction 
may remain preserved even in advanced stages 
of the disease [5]. The most important changes 
observed include hypertrophic remodeling [6], dias-
tolic dysfunction [7, 8] and impaired contractility [9]. 
Strain imaging has demonstrated to be the most 
appropriate method to evaluate the subtle changes 
in myocardial function that occur in patients with 
AS [10, 11] and global longitudinal strain (GLS), it 
is also the most useful parameter to independently 
predict mortality [12]. While improvement in strain 
parameters has been observed soon after surgi-
cal valve replacement [9, 13], evidence about the 
early benefits of TAVR in LV mechanics is scarce. 
The main objective of this study was to assess the 
immediate impact of TAVR on strain parameters.
Methods
Study population
This is a prospective cohort study conducted 
at ten centres in Europe. All patients with symp-
tomatic severe AS undergoing TAVR with either 
a self-expanding CoreValve system (Medtronic, 
Minneapolis, MN) or a mechanically expanded 
Lotus valve (Boston Scientific, Natick, MA) were 
eligible. Exclusion criteria included: poor echo-
cardiographic window (defined as two or more 
inadequately visualized myocardial segments 
[considering a 17-segment model]), the presence 
of atrial fibrillation (AF) at the initial evaluation, the 
existence of an unstable cardiac condition (such as 
an acute coronary syndrome or significant pericar-
dial effusion) or refusal to provide written informed 
consent. The patients were evaluated at two points 
in time, prior to the procedure, generally between 
24 and 48 h before the implant (visit 1 or V1), 
and on the planned discharge day (visit 2 or V2). 
The study was approved by our ethics committee 
and endorsed by the different committees at each 
participant center.
Demographic and clinical data
Collected variables regarding demographic and 
clinical data included age, sex, height, weight, body 
surface area, body mass index and New York Heart 
Association functional class. Comorbidities were 
obtained from a medical interview or by reviewing 
medical charts, and included hypertension, diabe-
tes, myocardial infarction, cerebrovascular disease, 
peripheral artery disease, and severe pulmonary 
obstructive disease.
Two-dimensional echocardiography
Echocardiographic examinations were per-
formed using available imaging equipment at each 
center, provided that the same machine was used 
for all the examinations of any given patient. The 
imaging devices employed include: Vivid E9 (GE 
Medical systems, Horten, Norway), iE33, HD11, 
EPIQ7 (Philips Medical Systems, Bothell, WA, 
USA) and Acuson S2000 (Siemens Medical Solu-
tion, Mountain view USA). The LV end-diastolic 
and end-systolic volume were obtained at the 
standard apical 4-chamber and 2-chamber views, 
LV ejection fraction (LVEF) was calculated using 
the Simpson method. GLS was computed from the 
apical 4-chamber, 2-chamber and 3-chamber views. 
Endocardial borders were traced by hand at an 
end-systolic and/or end-systolic frame, according 
to the vendor, and myocardial speckles were auto-
matically tracked throughout subsequent frames. 
Whenever necessary, tracking was manually cor-
rected. GLS was obtained as the average value of 
regional strains. Absolute increase and percentage 
change in GLS was calculated between V1 and V2.
Statistical analysis
Continuous variables were tested for normal-
ity of distribution with the Saphiro-Wilk test. Data 
is presented as mean ± standard deviation when 
normally distributed or median (interquartile 
range). The paired t test and Wilcoxon signed-rank 
test were used to compare pre- and post-procedural 
quantitative parameters. Categorical data were 
presented as numbers (percentages) and compared 
with the Pearson c2 test when appropriate. P values 
< 0.05 were considered significant. All statistical 
analyses were performed using Stata 13.0 (Stata-
Corp LLC, College Station, Texas).
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Results
Patient characteristics 
The patient flow chart is presented in Figure 1. 
A total of 172 patients who underwent TAVR at 
participant centres were assessed for eligibility. 
Sixty (35%) patients met the exclusion criteria, 
40 due to the presence of AF at the initial evaluation 
and 20 because of poor echocardiographic window, 
and were not enrolled in the study. Among the 
112 patients included, 6 (5.4%) patients were lost 
to follow up: 5 lacked a complete pre-discharge 
echocardiographic examination because of logisti-
cal reasons (i.e. prompt return to the reference 
hospital), and 1 died shortly after intervention. Fi-
nally, 14 patients had developed AF at the discharge 
analysis (including patients with a prior diagnostic 
of paroxysmal AF as well as new-onset AF), leaving 
a population of 92 patients for comparative analysis. 
Patient baseline characteristics are sum-
marized in Table 1. Concerning demographic and 
clinical variables among the 112 patients included, 
50% were female and 81.4 ± 6.4 years old, 76% 
had hypertension, 23% had diabetes mellitus, 
16% had history of coronary artery disease, and 
11% showed areas of scarred LV tissue.
All 112 patients had severe AS: mean value 
for aortic valve area (AVA) was 0.74 ± 0.22 cm2 
and mean pressure gradient was 46 ± 15 mmHg. 
A reduced LVEF of 50% or less was seen in 31 of 
112 patients (28%) and paradoxical low-flow state 
(LVEF > 50% and stroke volume index < 35 mL/m2) 
was seen in 27 of 112 patients (24%). Indexed LV 
mass was 145 ± 46 g/m2, with 75 (67%) patients 
having significant LV hypertrophy (considering 
≥ 132 g/m2 for men and ≥ 109 g/m2 in women as the 
cut-off for moderate hypertrophy).
Figure 1. Patient flow chart.
Table 1. Baseline characteristics.
Variable Value
Demographic and clinical variables
Age [years] 81.4 ± 6.4
Female 56 (50%)
Body surface area [m2] 1.73 ± 0.19
Body mass index [kg/m2] 26.48 ± 4.38
Hypertension 72 (76%)
Diabetes mellitus 38 (25%)
Coronary artery disease 15 (16%)
NYHA class II–IV 104 (93%)
Aortic valve severity
Aortic valve area [cm2] 0.74 ± 0.22
Indexed aortic valve area [cm2/m2] 0.44 ± 0.17
Mean pressure gradient [mmHg] 46.12 ± 15.34
Peak pressure gradient [mmHg] 76 ± 27
Geometry and systolic function
LV ejection fraction [%] 56 ± 12.2
LV end-diastolic volume [mL] 98.1 ± 36.6
Stroke volume [mL/m2] 67.5 ± 22.9
Indexed mass [g/m2] 145.4 ± 46.1
LV — left ventricular; NYHA — New York Heart Association
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Evolution of AS severity, LV mass  
and function and myocardial  
deformation parameters
The first echocardiographic examination (V1) 
was performed a median of 1 day [1, 2] prior to 
intervention and the second took place a median 
of 5 days [4–7] after the procedure.
The echocardiographic parameters measured 
at baseline (V1) and after the procedure (V2) are 
listed in Table 2. 
Predictably, parameters of AS severity suf-
fered a profound change after TAVR procedure, 
with a statistically significant increase in AVA (from 
0.73 ± 0.22 cm2 to 1.92 ± 0.6 cm2, p < 0.0001) and 
a significant decrease in transvalvular gradients 
(mean gradient from 47 ± 15 mmHg to 12 ± 8 
mmHg, p < 0.0001; peak gradient from 78 ± 26 
mmHg to 22 ± 13 mmHg, p < 0.0001). 
Regarding LV geometry, systolic function and 
mechanics, a significant decrease in LV mass was 
noted (from 145 ± 47 g/m2 to 130 ± 38 g/m2, p = 
= 0.0008) while systolic function remained globally 
unaltered, as statistically significant changes could 
not be seen in LVEF with the Simpson biplane 
method (56 ± 12% in V1 and 57 ± 11% in V2, p = 
= 0.1069) and in LV stroke volume (68 ± 24 mL/m2 
in V1 and 68 ± 23 mL/m2 in V2, p = 0.8136). Never-
theless, when stratified by basal LVEF (considering 
normal LVEF values those > 50% and abnormal 
those ≤ 50%), a modest improvement in this pa-
rameter could be noted in the group of patients 
with previous abnormal LVEF (from 40 ± 8% in 
V1 to 44 ± 11% in V2, p = 0.0343) and not in those 
with previous normal LVEF (from 62 ± 7% in V1 
to 63 ± 8% in V2, p = 0.6771). In contrast, GLS 
was significantly lower after the procedure –14.9 ± 
± 5.0% in V1 and –16.2 ± 5.1% in V2, p = 0.0057). 
Figure 2 presents box plots of GLS at each visit.
LV mechanics improvement according  
to demographic characteristics
In subgroup analysis considering demographic 
characteristics, a significant improvement in LV 
mechanics could only be seen in female patients, 
with an absolute increase of 1.8% in GLS be-
tween examinations in the female population (GLS 
–15.3 ± 4.49% at V1 and –17.1 ± 4.74% at V2, 
p = 0.0061) and 0.66% in the male population (GLS 
–14.7 ± 5.08% at V1 and –15.3 ± 4.93% at V2, 
p = 0.2525). Figure 3 presents box plots of GLS 
at each visit for each sex category. No other 
Table 2. Results of echocardiographic parameters of aortic stenosis severity, left ventricular (LV)  
geometry, LV systolic function and LV mechanics.
V1 V2 P
Aortic stenosis severity parameters
Aortic valve area [cm2] 0.73 ± 0.22 1.92 ± 0.6 < 0.0001
Indexed aortic valve area [cm2/m2] 0.43 ± 0.17 1.10 ± 0.036 < 0.0001
Mean pressure gradient [mmHg] 47 ± 15 12 ± 8 < 0.0001
Peak pressure gradient 78 ± 26 22 ± 13 < 0.0001
LV geometry, systolic function and mechanics parameters
LV indexed mass [g/m2] 145 ± 47 130 ± 38 0.0008
LV ejection fraction (Simpson method) [%] 56 ± 12 57 ± 11 0.1069
Stroke volume [mL/m2] 68 ± 24 68 ± 23 0.8136
Global longitudinal strain [%] –14.9 ± 5.0 –16.2 ± 5.1 0.0057
V1 — baseline; V2 — after the procedure
Figure 2. Box plots representing global longitudinal 
strain at each visit.
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differences could be seen in AS severity or LV sys-
tolic function parameters between sex categories.
LV mechanics improvement according  
to LV characteristics
When stratified according to LV systolic func-
tion by LVEF (Simpson Biplane method), those 
with reduced systolic function, defined as an 
LVEF of less than 50%, n = 24, experienced 
a greater improvement in GLS (from –11.1 ± 4.3% to 
–12.6 ± 4.3, p = 0.0152), than those with a pre-
served systolic function, defined as an LVEF of 
50% or superior, n = 68 (from –16.3 ± 4.5% to 
–17.4 ± 4.7%, p = 0.0473). Considering different de-
grees of systolic dysfunction (with mild systolic dys-
function defined as an LVEF between 40% to 49%, 
n = 12; moderate systolic dysfunction as an LVEF 
between 30% to 39%, n = 8; and severe systolic 
dysfunction as and LVEF inferior to 30%, n = 4), 
improvement in GLS was proportional to systolic 
dysfunction, with the greatest improvement in the 
group with severe systolic dysfunction, although 
statistical significance was not achieved in all 
categories, probably because of an insufficient 
number of subjects in each (from –12.9 ± 4.1% 
in V1 to –14.1 ± 3.8% in V2, p = 0.2202, in mild 
systolic dysfunction; from –9.6 ± 2.6% in V1 to 
–11.1 ± 4.3% in V2, p = 0.1821, in moderate sys-
tolic dysfunction; and from –6.0 ± 2.6% in V1 to 
–9.0 ± 3.7% in V2, p = 0.0418, in severe systolic 
dysfunction). Figure 4 presents box plots of GLS at 
each visit for each category of systolic function. In 
the subset of patients showing areas of scarred LV 
tissue (n = 12), a greater GLS improvement could 
be noted compared to those without scarred tissue 
(from –10.4 ± 2.7% to –12.9 ± 2.8%, p = 0.1622 
in patients with presence of scar compared to 
–15.7 ± 4.8% to –17.2 ± 4.9%, p = 0.036), although 
statistical significance was not reached, probably 
due to the small size of this subgroup.
LV mechanics improvement according  
to type of valve
When analyzed separately, only the group 
receiving a self-expanding valve showed a statisti-
cally significant improvement in GLS at this point 
in time; from –15.4 ± 4.8% to –18.3 ± 5.2% in 
the self-expanding valve group (p = 0.0002); from 
–15.2 ± 5.0% to –15.8 ± 4.5% in the mechanically-
expanded valve group (p = 0.3595). No difference 
could be seen in the improvement in mean and peak 
gradients or in the AVA after the procedure: mean 
gradient from 52 ± 13 mmHg to 10 ± 10 mmHg 
in the self-expanding valve group (p < 0.0001), 
from 43 ± 15 mmHg to 13 ± 6 mmHg in the 
mechanically-expanded valve (p < 0.0001); peak 
Figure 3. Box plots representing global longitudinal strain at each visit for each sex category. A. Female; B. Male.
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gradient from 88 ± 28 mmHg to 18 ± 16 mmHg in 
the self-expanding valve group (p < 0.0001), from 
71 ± 22 mmHg to 23 ± 11 mmHg in the mechani-
cally-expanded valve (p < 0.0001); AVA from 0.7 ± 
± 0.2 cm2 to 2.1 ± 0.7 cm2 in the self-expanding 
valve group (p < 0.0001), from 0.8 ± 0.2 cm2 
to 1.8 ± 0.6 cm2 in the mechanically-expanded 
valve group (p < 0.0001). However, a difference 
could be seen in LV systolic function using the 
Simpson biplane method between the two types 
of prosthesis, with only the self-expanding pros-
thesis achieving a significant increment (from 57 ± 
± 10 cm2 to 60 ± 10 cm2 in the self-expanding 
valve group (p = 0.0123), from 56 ± 13 cm2 to 
56 ± 13 cm2 in the mechanically-expanded valve 
group (p = 0.7380).
Discussion
The main findings of this study are as follow: 
(i) TAVR is associated with an immediate improve-
ment in LV mechanics, as demonstrated by GLS 
increase, (ii) this occurs although LV systolic 
function, as assessed by LVEF or stroke volume, 
remains unaltered, (iii) this improvement is re-
stricted to women and (iv) shows a trend toward 
being directly proportional to the degree of systolic 
dysfunction.
Patient population
It was considered that the population included 
in the present study accurately represents that 
of severe AS patients usually referred for TAVR 
procedure, and have similar characteristics to 
the population included in the intermediate-risk 
patient study [14].
Reverse remodeling in TAVR
Severe AS causes a chronic pressure overload 
that leads to pathologic remodeling in the form of 
concentric hypertrophy, with an increase in LV 
mass that results in an impaired diastolic function 
and a mostly preserved systolic function, although 
LV mechanics are usually impaired. TAVR causes 
an acute decrease in transvalvular gradient that 
could lead to an immediate improvement in LV 
mechanics, which could be a precursor of reverse 
remodeling, which in turn could lead to a reduction 
in LV mass and improvement in diastolic function in 
the long term. In this study, the observations which 
were restricted to the first days after TAVR, no 
change was noted in systolic function as assessed 
by LVEF through the Simpson biplane method, 
was largely normal prior to the procedure, but an 
otherwise significant increase in GLS was seen. 
In a considered opinion, this could represent the 
first landmark of an incipient reverse remodeling. 
Figure 4. Box plots representing global longitudinal strain at each visit for each systolic function category.
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An immediate reduction in indexed LV mass 
was also seen, a finding also seen in previous 
studies, both with TAVR and surgical replacement 
[15–17]. A correlation between time of perfor-
mance of the second echocardiographic examina-
tion and LV mass reduction could not be found 
(p = 0.1772). Given that this change could hardly 
be explained by changes in myocyte size or number, 
protein synthesis, organization of the sarcomere 
or fibrosis, it was proposed that this change could 
represent a reduction in myocardial edema, as seen 
in myocarditis [18].
In a stratified analysis according to gender, 
only female patients experienced a significant im-
provement in GLS. This finding is in line with other 
published studies suggesting that women may have 
better outcomes with TAVR that men, the nature 
of this association remains unknown [19].
In stratified analysis by LVEF, a strong trend 
could be noted towards a greater increase in GLS 
in patients with more severe dysfunction. Although 
only those with preserved ejection fraction or 
severe dysfunction experienced a statistically sig-
nificant improvement in GLS, failure to find statisti-
cally significant differences in mild and moderate 
impaired systolic function subcategories was likely 
due to a consequence of the small sample size of 
these subgroups. The finding of improvement in LV 
mechanics even once systolic dysfunction has been 
established could be a manifestation of reversible 
adverse LV remodeling, which would encourage 
the use of TAVR in this kind of patient.
In stratified analysis according to valve sub-
type, only the group receiving a self-expanding 
valve showed a statistically significant improve-
ment in GLS at this point in time. While both kinds 
of valve showed similar changes in transaortic 
gradients and AVA after the procedure, the group 
receiving the self-expanding valve achieved 
a statistically significant improvement in LV sys-
tolic function as assessed by the Simpson biplane 
method, which could in turn explain the difference 
in GLS improvement. Although previous studies 
have also shown an early improvement in LV sys-
tolic function with the self-expanding valve [20], 
the reason for this difference in early LV mechanic 
behaviour remains unclear and should be clarified 
in further studies.
Limitations of the study
The main limitation of the study was the 
use of different cardiac ultrasound machines and 
vendor-specific software in participant centers, 
which make absolute values of GLS for each visit 
non-comparable between participants of different 
centers. However, given that the same machine and 
software was used in each visit in any given patient, 
it was  believed the change in GLS was comparable 
between participants of different centers.
Radial and circumferential strain values were 
not collected in the study, mainly because GLS 
was more widespread and reproducible, and was 
considered to be a more relevant parameter of LV 
mechanics for clinical application. Thus, potential 
changes in radial and circumferential deformation 
could not be studied.
Conclusions
Although systolic function remained unaltered 
immediately after TAVR, an improvement in GLS 
could be appreciated soon after the procedure. This 
was found to occur only in women and be greater 
in patients with systolic dysfunction, although the 
present study lacks sufficient sample size to find 
a statistically significant difference in the small 
group of patients with impaired LVEF. Whether this 
finding continues to be noted in a more prolonged 
follow-up and its clinical implications need to be 
assessed in further studies.
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